Kevin Brady

Kevin Brady has over 20 years of experience in finance and accounting. Kevin is currently the Chief Financial Officer at Medpace. Prior to joining Medpace, Kevin served as the Vice President of Finance and Treasury at Myriad Genetics from September 2016 to November 2018. Kevin was also the Vice President and Corporate Controller at Assurex Health from May 2015 to August 2016. Assurex Health was acquired by Myriad Genetics in August 2016. Prior to Assurex Health, Kevin served as the Corporate Controller at Champion Window Mfg. from January 2014 to December 2015. From 2008 to 2009, Kevin was the Assistant Controller at The Folgers Coffee Company. Kevin spent 10 years at P&G from 2003 to 2013, where they held various positions including Group Manager of Financial Planning, Analysis and Hedging. Kevin began their career at Ernst & Young in 1997, where they worked for six years as an Audit Manager. Kevin Brady is a Certified Public Accountant (CPA) and holds a Bachelor’s degree in Accounting from the University of Cincinnati.

Kevin Brady works with Jennifer Ruth - Executive Director, Quality Assurance & Process Improvement, Jon Isaacsohn - Executive Vice President, and Brandon Ebken - Chief Information Officer. Kevin Brady reports to August Troendle, President & CEO.